For comparison, mutations that lacked either N-linked glycosylation site (Asn364Leu/Asn373Leu) or Ala242Glu, a known pathogenic Bartter syndrome type 3 mutation (31), also demonstrated diminished glycosylation compared with wild-type ClC-Kb. This evidence concerns the gene CLCNKB and Bartter disease type 3.